Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$20.30 +0.23 (+1.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amneal Pharmaceuticals (AMRX) Gains from Sales and Divestitures (2017 - 2020)

Updated

Amneal Pharmaceuticals (AMRX) recorded Gains from Sales and Divestitures of $123,000 in FY2020, down 98.3% from $7.26 million in FY2019.

Analysis

Amneal Pharmaceuticals (AMRX) Gains from Sales and Divestitures (2017 - 2020) Analysis & Trends

Starting with FY2017, Amneal Pharmaceuticals' Gains from Sales and Divestitures history includes 4 years.

  • Annual Gains from Sales and Divestitures has ranged from -$29.23 million in FY2017 to $7.26 million in FY2019 over the past five years.
  • Per Business Quant data, AMRX's Gains from Sales and Divestitures was $7.26 million in FY2019, -$2.96 million in FY2018 and -$29.23 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Amneal Pharmaceuticals 6.48 Bn 5.76 Bn 334.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 123,000.00
Dec 31, 2019 328,000.00
Jun 30, 2019 -1.89 Mn
Mar 31, 2019 8.82 Mn
Dec 31, 2018 -146,000.00
Sep 30, 2018 -2.81 Mn
Dec 31, 2017 -352,000.00
Sep 30, 2017 -28.88 Mn
API Access

Amneal Pharmaceuticals Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=AMRX&period=max&api_key=YOUR_API_KEY